Healthcare & Life Sciences
Aspreva
Canada
acquiredacquired
acquired
Stage
About
Aspreva was a Canadian specialty pharmaceutical company listed on NASDAQ in 2005 and acquired by Galenica in 2007 for $915 million.
Explore Aspreva's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.